Information Note
1 of every 22 people living with HIV
was affected by
a humanitarian emergency in 2013
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention ...approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive in randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
more
Policy
July 2012
Working Paper No. 3
HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
Rural Development through decent work
Themes: Rural Policy Briefs
WHO Progress Brief
Progress Brief
July 2017
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
Training for Health Care Providers
Facilitators’ Manual
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
Technical Report
AIDS Medicines and diagnostics service
July 2015
Technical Report
AIDS Medicines and diagnostics service
September 2016
Accelerating HIV prevention to reduce new infections by 75%